UNSPSC 51352404: Drospirenone/estradiol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class HS200. This VA Drug Class (HS200) classifies this compound as belonging to the group CONTRACEPTIVES, SYSTEMIC.

UNSPSC 51352404 Drospirenone/estradiol is a Commodity code for a combined oral contraceptive pharmaceutical product. State and local governments procure this medication primarily through public health agencies, Medicaid programs, and school-based health clinics to support family planning and reproductive health services for covered populations. The medication itself — a fixed-dose combination of the progestin drospirenone and the estrogen estradiol — is a prescription pharmaceutical supplied through established pharmaceutical distribution channels and state or local formularies.

The source provided contains no recent state or local contract opportunities solicited under this code, making it impossible to characterize the current issuing-body mix, geographic spread, or representative recent procurement activity. Pharmaceutical commodities at the drospirenone/estradiol level typically move through standing state Medicaid contracts, group purchasing organization agreements, and established health agency supply relationships rather than through time-bound competitive solicitations, which may explain the absence of recent RFP, RFQ, IFB, or ITB activity in the opportunity record.